ABSTRACT. Numerous studies have investigated the potential relationship between the human leukocyte antigen (HLA)-G 14-bp insertion/deletion (INS/DEL) polymorphisms and autoimmune disease (AID). However, published results are inconclusive. Our aim was to determine whether the 14-bp INS/DEL polymorphism in the HLA-G gene contributes to the risk of AID. A systemic literature search of the PubMed and EMBASE databases was conducted to identify eligible studies investigating the association of the HLA-G 14-bp INS/DEL polymorphism with AID. Our analysis included 11 publications involving a total of 6462 individuals. Overall, no significant association between the HLA-G 14-bp INS/DEL polymorphism and AID was detected in any comparison model. Further subgroup analyses based on AID types and ethnicity also revealed no significant associations. Our results suggest that the HLA-G 14-bp INS/DEL polymorphism is unrelated 15839-15847 (2015) to the development of AID. Further studies including larger sample sizes are warranted to confirm these results.
INTRODUCTION
The immune system plays an important role in recognizing foreign antigens and protecting against infections, facilitating species survival. However, when the body reacts to itself, immunity can become problematic. Autoimmunity is defined as a misdirected attack made by the immune system against the host as a result of a failing to recognize a self-antigen. This phenomenon is typically an innocuous finding, but has the potential to lead to a broad spectrum of complex autoimmune diseases (AIDs) (Amur et al., 2012) .
AID generally refers to a clinically distinct illness caused by an immune reaction to an otherwise normal molecule or tissue component of the subject's body (Cohen, 2014) . A total of 5-8% of the general population is affected by AIDs and at least 80 medical conditions are known to be associated with AIDs (Gleicher and Barad, 2007) . Recurrent and chronic courses and multiple organ involvement are commonly observed in AIDs.
Human leukocyte antigen (HLA)-G, a non-classical major histocompatibility complex class I molecule, plays an important role in regulating immune responses. HLA-G expression was initially thought to be restricted to the placenta. Recently, however, HLA-G expression has been detected in thymic epithelium, pancreas, intestine, and peripheral blood monocytes (Kovats et al., 1990; Crisa et al., 1997) . HLA-G molecules are generated through alternative splicing of the primary transcript of the gene (Ishitani and Geraghty, 1992) ; HLA-G has 7 isoforms, including 4 membranebound (HLA-G1-G4) isoforms and 3 secreted, soluble isoforms (HLA-G5-G7).
HLA-G exhibits immunotolerance functions, inducing apoptosis of activated CD8 + T cells (Fournel et al., 2000) , interactions with T regulatory cells (Du et al., 2011) , modulation of the activity of natural killer cells (Marchal-Bras-Goncalves et al., 2001 ) and dendritic cells (Liang et al., 2008) , and blocking of the allo-cytotoxic T lymphocyte response (Kapasi et al., 2000) .
Recent studies have revealed that HLA-G is expressed in numerous pathological conditions, such as psoriatic skin lesions, atopic dermatitis, pemphigus vulgaris, myositic lesions, multiple sclerosis, ulcerative colitis, and some cancers (Larsen and Hviid, 2009; Donadi et al., 2011) .
HLA-G production is controlled by several polymorphisms in the promoter (or 5'-upstream regulatory) region as well as a 14-bp insertion (INS)/deletion (DEL) in the 3'untranslated region. These polymorphisms modify interactions between the gene and transcriptional or posttranscriptional factors, respectively (Hviid et al., 2006) . Many association studies have focused on the 3'-untranslated region polymorphic sites that appear to play a pivotal role in the regulation of HLA-G expression by influencing the binding of specific microRNAs, affecting the stability of the HLA-G mRNA (Sabbagh et al., 2014) . The relationships between the HLA-G 14-bp INS/DEL polymorphism and many AIDs have been previously examined. However, the results of many of the association studies published to date have been inconclusive.
In this study, we performed a meta-analysis using all data published to date to assess the statistical evidence of the association between the HLA-G 14-bp INS/DEL polymorphism and AID risk.
MATERIAL AND METHODS

Search strategy
Case and control studies were searched in the PubMed, EMBASE, and Korean Studies Information Service System databases up to May 2014 without language restrictions. Relevant studies were identified using the terms: "HLA-G 14-bp or HLA-G insertion or HLA-G deletion" AND "polymorphism or polymorphisms or variant" AND "autoimmune or autoimmunity or autoimmune disease". Studies were restricted to humans. Additional studies were identified by a manual search of reference lists in original or review articles. If data or data subsets were published in more than one article, only the publication with the largest sample size was included.
Inclusion criteria
Studies were included if they met the following criteria: 1) studies that evaluated the association between the HLA-G 14-bp INS/DEL polymorphism (rs66554220) and autoimmune disease, 2) case-control study design, and 3) had detailed genotype frequencies for cases and controls.
Data extraction
Two investigators independently extracted data and reached consensus on all items. If the 2 investigators generated different results, they rechecked the data and reached a consensus through discussion. Data extracted from the selected articles included the first author's name, year of publication, country of origin, ethnicity of the study population, and numbers of cases and controls. Ethnicity was divided into Asian and Caucasian populations.
Statistical analysis
Before the effect estimation of HLA-G 14-bp INS/DEL polymorphism in AID, we first calculated the Hardy-Weinberg equilibrium of the HLA-G 14-bp INS/DEL polymorphism using the χ 2 test (http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2-alleles.html). The meta-analysis was performed using the Comprehensive Meta-Analysis software (BioStat, Inc., Englewood, NJ, USA). The pooled odds ratio (OR) and 95% confidence interval (CI) were used to investigate the association between autoimmune disease and the rs66554220 polymorphism in the HLA-G gene. A random-effect or fixed-effect model was used. OR, with the corresponding 95%CI, was calculated for the additive model
(INS/INS vs INS/DEL vs DEL/DEL), dominant model (INS/ INS and INS/DEL vs DEL/DEL), and recessive model (INS/INS vs INS/DEL and DEL/DEL), and allele (INS vs DEL).
A χ 2 test-based Q statistic test was performed to assess heterogeneity. We also assessed the effects of heterogeneity using the I 2 test. A significant Q test (P < 0.05) or I 2 > 50% indicated heterogeneity among the studies. The random-effect Mantel Haenszel method was used if the result of the Q test was P < 0.05 or the I 2 statistic was > 50 %, indicating statistically significant heterogeneity between studies. Otherwise, the fixed-effect Mantel Haenszel method was used. P values < 0.05 were considered to indicate statistical significance.
RESULTS
Study characteristics
A total of 70 studies were screened from the databases. Figure 1 shows that 11 articles, including 2704 cases and 3758 controls, were ultimately selected. The characteristics of the studies selected regarding the HLA-G 14-bp INS/DEL polymorphism and AID are summarized in Table 1 Table 2 ). In subanalyses, according to AID type, SLE and RA were analyzed. No association was detected between the HLA-G 14-bp INS/DEL polymorphism and SLE or RA (Table  3) . These results suggest that the HLA-G 14-bp INS/DEL polymorphism does not contribute to the development of AID. The random model was adopted if the result of the Q test was P < 0.05 or the I 2 statistic was > 50 %, and the fixed model was used if the result of the Q test was P > 0.05 or the I 2 statistic was <50%. OR, odds ratio; CI, confidence interval; INS, insertion; DEL, deletion. The random model was adopted if the result of the Q test was P < 0.05 or the I 2 statistic was > 50%, and the fixed model was used if the result of the Q test was P > 0.05 or the I 2 statistic was < 50%. OR, odds ratio; CI, confidence interval; INS, insertion; DEL, deletion.
Quantitative synthesis
DISCUSSION
Since the 14-bp INS/DEL polymorphism was first reported by Harrison et al. (1993) , the association between the HLA-G 14-bp INS/DEL polymorphism and disease has been a research focus. Many studies have investigated the complications of pregnancy, such as recurrent spontaneous abortion and pre-eclampsia. Several studies have suggested that the HLA-G 14-bp INS/DEL polymorphism is associated with AIDs, such as SLE (Rizzo et al., 2008; Veit et al., 2009; Wu et al., 2009; Consiglio et al., 2011) , RA Veit et al., 2008) , juvenile idiopathic arthritis (Veit et al., 2008) , multiple sclerosis (Kroner et al., 2007) , ulcerative colitis (Glas et al., 2007) , Crohn's disease (Glas et al., 2007) , idiopathic dilated cardiomyopathy (Lin et al., 2007) , pemphigus vulgaris, and non-segmental vitiligo (Jeong et al., 2014) .
Among polymorphisms in the HLA-G gene, the 14-bp INS/DEL polymorphism in the 3'-untranslated region of exon 8 has been shown to play an important role in the post-transcriptional regulation of HLA-G (Dahl and Hviid, 2012) . The 14-bp INS/DEL polymorphism likely affects mRNA stability and expression; the presence of the 14-bp INS allele has been associated with lower levels of HLA-G mRNA and, to some extent, with lower levels of soluble HLA-G (Rebmann et al., 2001; Hviid et al., 2003 Hviid et al., , 2004 . Decreased soluble HLA-G plasma concentrations may lead to chronic activation of inflammatory cells and contribute to the development of AIDs (Larsen and Hviid, 2009) .
To explore the potential relationship between the HLA-G 14-bp INS/DEL polymorphism and AID risk, numerous case-control studies have been conducted. For SLE, the results obtained were inconclusive and even contradictory. Studies examining juvenile idiopathic arthritis, ulcerative colitis, Crohn's disease, idiopathic dilated cardiomyopathy, pemphigus vulgaris, and nonsegmental vitiligo showed significant associations between the 14-bp INS/DEL and disease risk, while RA and multiple sclerosis showed no association. In SLE, to date, conflicting results have been reported. Rizzo et al. (2008) reported an increased frequency of the 14-bp INS among Italian patients, and Veit et al. (2009) and Consiglio et al. (2011) reported an excess of heterozygotes in Brazilian patients. However, Wu et al. (2009) detected no association between the HLA-G 14-bp INS/DEL polymorphism and SLE among Chinese patients. In the current meta-analysis, we found no association between this polymorphism and SLE. Rizzo et al. (2009) and Veit et al. (2008) studied the association between the 14-bp INS/DEL polymorphism and RA. Both studies showed consistent results: there was no difference between genotype and allelic frequencies for this polymorphism. A single study for each of the associations between this polymorphism and JIR, multiple sclerosis, ulcerative colitis, Crohn's disease, idiopathic dilated cardiomyopathy, pemphigus vulgaris, and non-segmental vitiligo has been reported (Gazit et al., 2004; Glas et al., 2007; Kroner et al., 2007; Lin et al., 2007; Veit et al., 2008; Jeong et al., 2014) . Thus, we did not perform AID subtype analyses of these cases, and the results should be interpreted cautiously.
This is the first meta-analysis to assess the relationship between polymorphisms in HLA-G 14-bp INS/DEL and the genetic susceptibility to AIDs. In the present meta-analysis, in total, 2704 cases and 3758 controls from 11 case control studies were included. Overall, our results showed no association between the HLA-G 14bp INS/DEL polymorphism and genetic susceptibility to AID, including SLE, RA, JIR, multiple sclerosis, ulcerative colitis, Crohn's disease, idiopathic dilated cardiomyopathy, pemphigus vulgaris, and non-segmental vitiligo.
The current meta-analysis had several limitations. First, the etiological mechanisms of AID are complex, in which gene-gene and gene-environment interactions are involved. It is possible that the current polymorphism has a partial effect of the development of AID, which would not be detected readily by meta-analysis. Second, the reports in this meta-analysis were obtained from the PubMed, EMBASE, and Korean Studies Information Service System databases. Thus, there is a possibility of publication bias. Third, the numbers of studies and individual sample sizes included in our pooled analysis were not sufficiently large for comprehensive analysis, particularly for AID subtype analyses, and further research is needed.
In conclusion, we conducted a meta-analysis of the HLA-G 14-bp INS/DEL polymorphism and the risk of AID development. Our results demonstrate that the HLA-G 14-bp INS/DEL polymorphism does not contribute to overall AID susceptibility. However, further well-designed studies with larger sample sizes are needed to confirm our results.
